PRESS RELEASE published on 02/03/2026 at 15:35, 1 month 22 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.69% interest in NCC Group plc in a Form 8.3 filing under the Takeover Code Form 8.3 Disclosure Takeover Code Vanguard Group NCC Group Plc
BRIEF published on 02/02/2026 at 16:20, 1 month 23 days ago Vanguard Group Discloses Key Positions in Rio Tinto Form 8.3 Takeover Code Vanguard Group Investment Disclosure Rio Tinto
BRIEF published on 02/02/2026 at 16:20, 1 month 23 days ago Le groupe Vanguard dévoile ses principales participations dans Rio Tinto Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Rio Tinto Information Sur Les Investissements
PRESS RELEASE published on 02/02/2026 at 16:15, 1 month 23 days ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation The Vanguard Group, Inc. discloses 4.45% and 6.81% interests in Rio Tinto plc and Rio Tinto Limited respectively, through stock ownership. Additional dealings detailed The Vanguard Group, Inc. Disclosure Stock Ownership Rio Tinto Plc Rio Tinto Limited
BRIEF published on 02/02/2026 at 16:11, 1 month 23 days ago Vanguard Group's Position Disclosure in JTC plc Takeover Code Securities Disclosure Vanguard Group Investment Activity JTC Plc
BRIEF published on 02/02/2026 at 16:11, 1 month 23 days ago Déclaration de position de Vanguard Group dans JTC plc Groupe Vanguard Code De Prise De Contrôle Activité D'investissement Information Sur Les Valeurs Mobilières JTC Plc
BRIEF published on 02/02/2026 at 16:10, 1 month 23 days ago The Vanguard Group Discloses Significant Position in Glencore plc The Vanguard Group Takeover Code Shareholding Disclosure Glencore Plc February 2026
BRIEF published on 02/02/2026 at 16:10, 1 month 23 days ago Le groupe Vanguard révèle une participation significative dans Glencore plc Code De Prise De Contrôle Le Groupe Vanguard Déclaration Relative À L'actionnariat Glencore Plc Février 2026
BRIEF published on 02/02/2026 at 16:08, 1 month 23 days ago The Vanguard Group Discloses Investment in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel The Vanguard Group Investment Disclosure Avadel Pharmaceuticals
BRIEF published on 02/02/2026 at 16:08, 1 month 23 days ago Le groupe Vanguard annonce un investissement dans Avadel Pharmaceuticals Le Groupe Vanguard Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA Information Sur Les Investissements
Published on 03/26/2026 at 08:05, 1 hour 34 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 44 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 59 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 9 hours 9 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 24 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:20, 18 minutes ago yoummday Wins a Texas Instruments 2025 Supplier Excellence Award
Published on 03/26/2026 at 09:05, 33 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 38 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 09:00, 38 minutes ago Original-Research: INDUS Holding AG (von NuWays AG): BUY
Published on 03/26/2026 at 07:30, 2 hours 9 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 2 hours 9 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 14 hours 45 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
